MCRA Assists NeuroMetrix with obtaining FDA Breakthrough Device Designation and Marketing Authorization in One Year
MCRA's Regulatory Team was retained by NeuroMetrix to lead the strategy and development of a De Novo submission to the...
MCRA's Regulatory Team was retained by NeuroMetrix to lead the strategy and development of a De Novo submission to the...
Quantitative biomarkers of demyelination can improve clinical trial design and accelerate development of disease-modifying therapeutics SAN FRANCISCO, July 14, 2022...
Differentiation amongst these pipeline agents will hinge on ease of access, easy-to-use companion diagnostics, and safety EXTON, Pa., July 14,...
North Boulder Chiropractic and Restoration Neurology Onboard EYE-SYNC technology to improve patient care with objective data Palo Alto, CA—October 7,...